[1]Mehlen P,Puisieux A.Metastasis:a question of life or death [J].Nat Rev Cancer,2006,6(6):449-458.
[2]Tan C,Peng L,Zeng X,et al.Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China [J].PLoS One,2013,8(12):e83396.
[3]Fock KM.Review article:the epidemiology and prevention of gastric cancer [J].Aliment Pharmacol Ther,2014,40(3):250-260.
[4]Stein U,Walther W,Arlt F,et al.MACC1,a newly identified key regulator of HGF-MET signaling,predicts colon cancer metastasis [J].Nat Med,2009,15(1):59-67.
[5]Stein U,Dahlmann M,Walther W.MACC1 - more than metastasis? Facts and predictions about a novel gene [J].J Mol Med (Berl),2010,88(1):11-18.
[6]Lee YJ,Park HJ,Woo SY,et al.RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages[J].J Pharmacol Exp Ther,2014,350(3):563-577.
[7]Huang Y,Zhang H,Cai J,et al.Overexpression of MACC1 and Its significance in human breast cancer progression [J].Cell Biosci,2013,3(1):16.
[8]Ding Y,Wang Y,Chen J,et al.p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade [J].Tumour Biol,2014,35(4):3119-3123.
[9]Yang T,Kong B,Kuang YQ,et al.Overexpression of MACC1 protein and its clinical implications in patients with glioma[J].Tumour Biol,2014,35(1):815-819.
[10]Yang Feng,Wang Lei,Zhong Daixing,et al.Expression and prognostic significance of MACC-1 and C-met in esophageal cancer[J].Modern Oncology,2015,23(13):1843-1846.[杨锋,王磊,钟代星,等.MACC1和C-met蛋白在食管癌中的表达及意义[J].现代肿瘤医学,2015,23(13):1843-1846.]
[11]Zhu M,Xu Y,Mao X,et al.Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer [J].Pathol Oncol Res,2013,19(4):749-753.
[12]Shirahata A,Fan W,Sakuraba K,et al.MACC 1 as a marker for vascular invasive hepatocellular carcinoma [J].Anticancer Res,2011,31(3):777-780.
[13]Kang N,Gores GJ,Shah VH.Hepatic stellate cells:partners in crime for liver metastases[J]?Hepatology,2011,54(2):707-713.
[14]Chang HR,Chen PN,Yang SF,et al.Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro,inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel [J].Mol Carcinog,2011,50(10):811-823.
[15]Rink M,Chun FK,Robinson B,et al.Tissue-based molecular markers for renal cell carcinoma [J].Minerva Urol Nefrol,2011,63(4):293-308.
[16]Okabe H,Beppu T,Hayashi H,et al.Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma [J].Ann Surg Oncol,2009,16(9):2555-2564.
[17]Ueda K,Iwahashi M,Matsuura I,et al.Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist,NK4,suppresses peritoneal metastases of gastric cancer in nude mice [J].Eur J Cancer,2004,40(14):2135-2142.
[18]Zhao L,Yasumoto K,Kawashima A,et al.Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer [J].Cancer Sci,2013,104(12):1640-1646.